Where Will Meta Platforms Stock Be in 3 Years?
Meta Platforms ( META 0.35%) stock has been in fine form on the market over the past three years, delivering healthy gains of 116% to investors and outperforming the 37% increase in the Nasdaq ...
Meta gives heads-up ahead of performance-based job cuts next week - report
Meta Platforms (META) has given its employees a heads-up on what to expect on Monday when the social media and tech giant ...
Internal Meta memo shows how its performance-based cuts will work
Janelle Gale, Meta's vice president of human resources, told staffers in a post on Meta's internal Workplace forum about what ...
Delcath Systems: Strong Position In Metastatic Uveal Melanoma, But Broader Growth Challenges Ahead
Delcath Systems markets Hepzato Kit for the treatment of uveal melanoma with unresectable hepatic metastases. Click here to read my analysis of DCTH stock.